177 related articles for article (PubMed ID: 21216092)
1. Gambogic acid enhances proteasome inhibitor-induced anticancer activity.
Huang H; Chen D; Li S; Li X; Liu N; Lu X; Liu S; Zhao K; Zhao C; Guo H; Yang C; Zhou P; Dong X; Zhang C; Guanmei ; Dou QP; Liu J
Cancer Lett; 2011 Feb; 301(2):221-8. PubMed ID: 21216092
[TBL] [Abstract][Full Text] [Related]
2. The combination of proteasome inhibitors bortezomib and gambogic acid triggers synergistic cytotoxicity in vitro but not in vivo.
Liu N; Huang H; Xu L; Hua X; Li X; Liu S; Yang C; Zhao C; Zhao C; Li S; Dou QP; Liu J
Toxicol Lett; 2014 Jan; 224(3):333-40. PubMed ID: 24291039
[TBL] [Abstract][Full Text] [Related]
3. Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells.
Yang W; Monroe J; Zhang Y; George D; Bremer E; Li H
Cancer Lett; 2006 Nov; 243(2):217-27. PubMed ID: 16413676
[TBL] [Abstract][Full Text] [Related]
4. Calcium channel blocker verapamil accelerates gambogic acid-induced cytotoxicity via enhancing proteasome inhibition and ROS generation.
Liu N; Huang H; Liu S; Li X; Yang C; Dou QP; Liu J
Toxicol In Vitro; 2014 Apr; 28(3):419-25. PubMed ID: 24373880
[TBL] [Abstract][Full Text] [Related]
5. Proteasome inhibitors abolish cell death downstream of caspase activation during anti-microtubule drug-induced apoptosis in leukemia cells.
Nagy K; Petak I; Imre G; Barna G; Gezane-Csorba M; Sebestyen A; Houghton JA; Mihalik R; Kopper L
Anticancer Res; 2005; 25(5):3321-6. PubMed ID: 16101145
[TBL] [Abstract][Full Text] [Related]
6. Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells.
Nencioni A; Wille L; Dal Bello G; Boy D; Cirmena G; Wesselborg S; Belka C; Brossart P; Patrone F; Ballestrero A
Clin Cancer Res; 2005 Jun; 11(11):4259-65. PubMed ID: 15930365
[TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibitor interacts synergistically with autophagy inhibitor to suppress proliferation and induce apoptosis in hepatocellular carcinoma.
Hui B; Shi YH; Ding ZB; Zhou J; Gu CY; Peng YF; Yang H; Liu WR; Shi GM; Fan J
Cancer; 2012 Nov; 118(22):5560-71. PubMed ID: 22517429
[TBL] [Abstract][Full Text] [Related]
8. Proteasome inhibition-induces endoplasmic reticulum dysfunction and cell death of human cholangiocarcinoma cells.
Ustundag Y; Bronk SF; Gores GJ
World J Gastroenterol; 2007 Feb; 13(6):851-7. PubMed ID: 17352013
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibitor-induced apoptosis of glioma cells involves the processing of multiple caspases and cytochrome c release.
Wagenknecht B; Hermisson M; Groscurth P; Liston P; Krammer PH; Weller M
J Neurochem; 2000 Dec; 75(6):2288-97. PubMed ID: 11080180
[TBL] [Abstract][Full Text] [Related]
10. The TRAIL apoptotic pathway mediates proteasome inhibitor induced apoptosis in primary chronic lymphocytic leukemia cells.
Kabore AF; Sun J; Hu X; McCrea K; Johnston JB; Gibson SB
Apoptosis; 2006 Jul; 11(7):1175-93. PubMed ID: 16699949
[TBL] [Abstract][Full Text] [Related]
11. Gambogic acid-induced degradation of mutant p53 is mediated by proteasome and related to CHIP.
Wang J; Zhao Q; Qi Q; Gu HY; Rong JJ; Mu R; Zou MJ; Tao L; You QD; Guo QL
J Cell Biochem; 2011 Feb; 112(2):509-19. PubMed ID: 21268072
[TBL] [Abstract][Full Text] [Related]
12. A coordinated action of Bax, PUMA, and p53 promotes MG132-induced mitochondria activation and apoptosis in colon cancer cells.
Ding WX; Ni HM; Chen X; Yu J; Zhang L; Yin XM
Mol Cancer Ther; 2007 Mar; 6(3):1062-9. PubMed ID: 17363499
[TBL] [Abstract][Full Text] [Related]
13. TNF potentiates anticancer activity of bortezomib (Velcade) through reduced expression of proteasome subunits and dysregulation of unfolded protein response.
Nowis D; McConnell EJ; Dierlam L; Palamarchuk A; Lass A; Wójcik C
Int J Cancer; 2007 Jul; 121(2):431-41. PubMed ID: 17373661
[TBL] [Abstract][Full Text] [Related]
14. Inducible nitric oxide synthase mediates MG132 lethality in leukemic cells through mitochondrial depolarization.
Chao TH; Chang MY; Su SJ; Su SH
Free Radic Biol Med; 2014 Sep; 74():175-87. PubMed ID: 24909615
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of proteasome function induced apoptosis in gastric cancer.
Fan XM; Wong BC; Wang WP; Zhou XM; Cho CH; Yuen ST; Leung SY; Lin MC; Kung HF; Lam SK
Int J Cancer; 2001 Aug; 93(4):481-8. PubMed ID: 11477551
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of beta-catenin and inhibition of beta-catenin-mediated transactivation.
Cervello M; Giannitrapani L; La Rosa M; Notarbartolo M; Labbozzetta M; Poma P; Montalto G; D'Alessandro N
Int J Mol Med; 2004 May; 13(5):741-8. PubMed ID: 15067380
[TBL] [Abstract][Full Text] [Related]
17. Gambogic acid induces apoptosis in diffuse large B-cell lymphoma cells via inducing proteasome inhibition.
Shi X; Lan X; Chen X; Zhao C; Li X; Liu S; Huang H; Liu N; Zang D; Liao Y; Zhang P; Wang X; Liu J
Sci Rep; 2015 Apr; 5():9694. PubMed ID: 25853502
[TBL] [Abstract][Full Text] [Related]
18. Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition.
An WG; Hwang SG; Trepel JB; Blagosklonny MV
Leukemia; 2000 Jul; 14(7):1276-83. PubMed ID: 10914553
[TBL] [Abstract][Full Text] [Related]
19. Induction and attenuation of neuronal apoptosis by proteasome inhibitors in murine cortical cell cultures.
Suh J; Lee YA; Gwag BJ
J Neurochem; 2005 Nov; 95(3):684-94. PubMed ID: 16144541
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of active caspase 8 as a mechanism of acquired TRAIL resistance in mismatch repair-proficient colon carcinoma cell lines.
Van Geelen CM; Pennarun B; Ek WB; Le PT; Spierings DC; De Vries EG; De Jong S
Int J Oncol; 2010 Oct; 37(4):1031-41. PubMed ID: 20811726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
